Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Osaka Tax Bureau Challenges Ruling on Shionogi Case
March 27, 2020
- JCR Acquiring ArmaGen to Expedite Drug Development for Lysosomal Diseases
March 27, 2020
- Eisai Files CTCL/PTCL Drug at MHLW Request
March 27, 2020
- Yoshindo Curbs Shipments of Tranexamic Acid as Coronavirus Hits API Supplies
March 27, 2020
- Ono, BMS Submit Opdivo/Yervoy Duo for NSCLC in Combination with Chemo
March 27, 2020
- Takeda to Introduce Fronteo’s Drug Discovery Support AI System
March 27, 2020
- Roche Diagnostics Files New Coronavirus Test in Japan
March 27, 2020
- Pfizer Japan Extends Voluntary Ban on Doctor Visits to April 10
March 27, 2020
- Otsuka’s PDE4 Inhibitor Difamilast Delivers Positive Data for Atopic Dermatitis in Japan PIII
March 27, 2020
- COVID-19-Disrupted Air Freight Hitting Commodity Transports, but No Major Impact So Far on Drugs
March 26, 2020
- Fujifilm Launches Contract Services for Process Development, Manufacturing of Liposome Formulations
March 26, 2020
- Asahi Kasei’s US Subsidiary Turbocharges Ventilator Production amid Coronavirus Outbreak
March 26, 2020
- Face Mask Shortages Crippling Drug Makers’ Business Activities, Travel Restrictions Could Delay Approval
March 26, 2020
- Aspen Japan President to Lead Sandoz K.K.
March 26, 2020
- Boehringer Ingelheim Recalling Alesion after Impurities Detected
March 25, 2020
- Astellas Inks Biotech R&D Pact for Next-Gen I/O Therapy
March 25, 2020
- AnGes Now Ready to Launch Preclinical Study for Coronavirus DNA Vaccine
March 25, 2020
- Nippon Chemiphar Snaps Up Japan Rights for Tumor Microenvironment Therapy from Delta-Fly
March 25, 2020
- Novartis Japan to Shed Oncology Staffers amid Overall Downscaling
March 24, 2020
- Chugai Mulling Japan Actemra Trial for COVID-19; Sanofi Says No Kevzara Plan for Now
March 24, 2020
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…